RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY.

Lin, Chun-Yuan; Wu, Yu-Hsin; Wang, Hong-Song; Chen, Ping-Kun; Lin, Yuan-Fu; Chien, I-Chia

Lin, Chun-Yuan; Wu, Yu-Hsin; Wang, Hong-Song; Chen, Ping-Kun; Lin, Yuan-Fu; Chien, I-Chia.

Afiliação

Lin CY; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Wu YH; Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nantou, Taiwan.
Wang HS; National Changhua University of Education, Changhua, Taiwan.
Chen PK; National Changhua University of Education, Changhua, Taiwan.
Lin YF; Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan.
Chien IC; Department of psychiatry, Changhua Hospital, Ministry of Health and Welfare, Chanhua, Taiwan.

Depress Anxiety ; 33(5): 435-43, 2016 05.

Article em En | MEDLINE | ID: mdl-26990119

Assuntos

Antipsicóticos/uso terapêutico; Transtorno Depressivo Maior/tratamento farmacológico; Transtorno Depressivo Maior/epidemiologia; Diabetes Mellitus Tipo 2/epidemiologia; Adulto; Fatores Etários; Estudos de Coortes; Comorbidade; Feminino; Humanos; Incidência; Masculino; Fatores de Risco; Taiwan/epidemiologia

Palavras-chave

depression; diabetes mellitus (DM); major depressive disorder (MDD); pharmacoepidemiology; pharmacotherapy; second-generation antipsychotic (SGA); treatment; treatment resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Transtorno Depressivo Maior / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google